CAS 1306763-57-4；Intermediate of Ozanimod CAS NO.1306763-57-4

Shanghai Caerulum Pharma Discovery was established in 2012 as an integrated CRO (Contract Research Organization), providing professional chemical services. As a customer-oriented company, Caerulum Pharma Discovery has distinguished itself from others in providing worldwide customers with cost-effective and efficient services and transparent communications to expedite the drug discovery and development.

Caerulum Pharma Discovery has over 1300 square meters of laboratory space, equipped with over 30 fume hoods in 9 laboratories.

Caerulum Pharma Discovery has built its capabilities in the production of APIs，intermediates and novel synthetic building blocks. APIs and intermediates projects have reached diabetes, cancer, cardiovascular and other therapeutic areas.

Caerulum Pharma Discovery itemizes cost analysis for the customers to understand the scope of the projects. Conference calls and email will be preceded to update the progress of ongoing projects, with the weekly report including detailed information of each step of every batch.

Caerulum Pharma Discovery strictly honors the confidentiality to protect any intellectual property of its customers. In the meantime, Caerulum Pharma Discovery will always stick to the principle of no infringement of the patents.

Caerulum Pharma Discovery, YOUR reliable and efficient source of chemical services!

The key intermediate of Ozanimod; relative intermediates are available as well.

Purity over 99%, Chiral HPLC is 100%

HNMR, HPLC and Chiral HPLC are available

Custom synthesis is acceptable;Capacity is over 500g

ROS, COA, MOA and MSDS will come along with consignment.